{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:47:32Z","timestamp":1773294452533,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1007\/s11910-003-0004-2","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T12:05:59Z","timestamp":1180699559000},"page":"285-288","source":"Crossref","is-referenced-by-count":30,"title":["Tourette\u2019s syndrome: Are stimulants safe?"],"prefix":"10.1007","volume":"3","author":[{"given":"Roger","family":"Kurlan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"4_CR1","unstructured":"Physicians Desk Reference, edn 54. Montvale, NJ: Medical Economics Data; 2000."},{"key":"4_CR2","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1212\/WNL.39.12.1625","volume":"39","author":"R Kurlan","year":"1989","unstructured":"Kurlan R: Tourette\u2019s syndrome: current concepts. Neurology 1989, 39:1625\u20131630.","journal-title":"Neurology"},{"key":"4_CR3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00005792-199101000-00002","volume":"70","author":"HS Singer","year":"1991","unstructured":"Singer HS, Walkup JT: Tourette syndrome and other tic disorders: diagnosis, pathophysiology and treatment. Medicine (Baltimore) 1991, 70:15\u201332.","journal-title":"Medicine (Baltimore)"},{"key":"4_CR4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3949\/ccjm.53.2.127","volume":"53","author":"G Erenberg","year":"1986","unstructured":"Erenberg G, Cruse PR, Rothner AD: Tourette syndrome: an analysis of 200 pediatric and adolescent cases. Clev Clin Q 1986, 53:127\u2013131.","journal-title":"Clev Clin Q"},{"key":"4_CR5","first-page":"223","volume-title":"Tourette\u2019s Syndrome and Tic Disorders","author":"RA Hagin","year":"1988","unstructured":"Hagin RA, Kugler J: School problems associated with Tourette\u2019s syndrome. In Tourette\u2019s Syndrome and Tic Disorders. Edited by Cohen DJ, Bruun RD, Leckman JF. New York: John Wiley and Sons; 1988:223\u2013236."},{"key":"4_CR6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ana.410300105","volume":"30","author":"R Kurlan","year":"1991","unstructured":"Kurlan R, Fett K, Parry K, et al.: School problems in Tourette\u2019s syndrome [abstract]. Ann Neurol 1991, 30:275\u2013276.","journal-title":"Ann Neurol"},{"key":"4_CR7","first-page":"63","volume-title":"Tourette\u2019s Syndrome: Tics, Obsessions, Compulsions","author":"IT Walkup","year":"1999","unstructured":"Walkup IT, Kahn S, Schuerholz L: Phenomenology and natural history of tic-related ADHD and learning disabilities. In Tourette\u2019s Syndrome: Tics, Obsessions, Compulsions. Edited by Leckman JF, Cohen DJ. New York: Wiley; 1999:63\u201379."},{"key":"4_CR8","first-page":"435","volume":"37","author":"DE Comings","year":"1985","unstructured":"Comings DE, Comings BG: Tourette syndrome: clinical and psychological aspects of 250 cases. Am J Hum Genet 1985, 37:435\u2013450.","journal-title":"Am J Hum Genet"},{"key":"4_CR9","first-page":"701","volume":"41","author":"DE Comings","year":"1987","unstructured":"Comings DE, Comings BG: A controlled study of Tourette syndrome, I: attention-deficit disorder, learning disorders, and school problems. Am J Hum Genet 1987, 41:701\u2013751.","journal-title":"Am J Hum Genet"},{"key":"4_CR10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00004583-198807000-00005","volume":"27","author":"J Sverd","year":"1988","unstructured":"Sverd J, Curley AD, Jandorf L, Volker L: Behavior disorder and attention deficits in boys with Tourette syndrome. J Am Acad Child Adolesc Psychiatry 1988, 27:413\u2013417.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"4_CR11","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1212\/WNL.43.9.1712","volume":"43","author":"S Parks","year":"1993","unstructured":"Parks S, Como PG, Cui L, Kurlan R: The early course of the Tourette\u2019s syndrome clinical spectrum. Neurology 1993, 43:1712\u20131715.","journal-title":"Neurology"},{"key":"4_CR12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1176\/ajp.120.1.80","volume":"120","author":"H Singer","year":"1963","unstructured":"Singer H: Gilles de la Tourette\u2019s disease. Am J Psychiatry 1963, 120:80\u201381.","journal-title":"Am J Psychiatry"},{"key":"4_CR13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00002826-199210000-00010","volume":"15","author":"MM Robertson","year":"1992","unstructured":"Robertson MM, Eapen V: Pharmacologic controversy of CNS stimulants in Gilles de la Tourette\u2019s syndrome. Clin Neuropharmacol 1992, 15:408\u2013425.","journal-title":"Clin Neuropharmacol"},{"key":"4_CR14","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.35.9.1346","volume":"35","author":"G Erenberg","year":"1985","unstructured":"Erenberg G, Cruse RP, Rothner AD: Gilles de la Tourette\u2019s syndrome: effect of stimulant drugs. Neurology 1985, 35:1346\u20131348.","journal-title":"Neurology"},{"key":"4_CR15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1212\/WNL.36.2.232","volume":"36","author":"PA Price","year":"1986","unstructured":"Price PA, Leckman JF, Pauls DL, et al.: Gilles de la Tourette\u2019s syndrome. Neurology 1986, 36:232\u2013237.","journal-title":"Neurology"},{"key":"4_CR16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ana.410020113","volume":"2","author":"GS Golden","year":"1977","unstructured":"Golden GS: The effect of central nervous system stimulants on Tourette syndrome. Ann Neurol 1977, 2:69\u201370.","journal-title":"Ann Neurol"},{"key":"4_CR17","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.1982.03320370043028","volume":"247","author":"TL Lowe","year":"1982","unstructured":"Lowe TL, Cohen DJ, Detlor J, et al.: Stimulant medications precipitate Tourette\u2019s syndrome. JAMA 1982, 247:1729\u20131731.","journal-title":"JAMA"},{"key":"4_CR18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ana.410120408","volume":"12","author":"HS Singer","year":"1982","unstructured":"Singer HS, Butler IJ, Tune LE, et al.: Dopaminergic dysfunction in Tourette syndrome. Ann Neurol 1982, 12:361\u2013366.","journal-title":"Ann Neurol"},{"key":"4_CR19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0010-440X(81)90084-5","volume":"22","author":"AK Shapiro","year":"1981","unstructured":"Shapiro AK, Shapiro E: Do stimulants provoke, cause, or exacerbate tics and Tourette syndrome? Compr Psychiatry 1981, 22:265\u2013273.","journal-title":"Compr Psychiatry"},{"key":"4_CR20","first-page":"424","volume":"28","author":"RJ Konkol","year":"1990","unstructured":"Konkol RJ, Fischer M, Newby RF: Double-blind, placebo-controlled stimulant trial in children with Tourette;s syndrome and attention deficit-hyperactivity disorder [abstract]. Ann Neurol 1990, 28:424.","journal-title":"Ann Neurol"},{"key":"4_CR21","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/00004583-198907000-00016","volume":"28","author":"J Sverd","year":"1989","unstructured":"Sverd J, Gadow KG, Paolicelli LM: Methylphenidate treatment of attention-deficit hyperactivity disorder in boys with Tourette\u2019s syndrome. J Am Acad Child Adolesc Psychiatry 1989, 28:574\u2013579.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"4_CR22","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/00004583-199205000-00012","volume":"31","author":"KG Gadow","year":"1992","unstructured":"Gadow KG, Nolan EE, Sverd J: Methylphenidate in hyperactive boys with comorbid tic disorder 1. Short-term behavioral effects in school settings. J Am Acad Child Adolesc Psychiatry 1992, 31:462\u2013471.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"4_CR23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00004583-198403000-00005","volume":"23","author":"ED Caine","year":"1984","unstructured":"Caine ED, Ludlow CL, Polinsky RJ, Ebert MH: Provocative drug testing in Tourette\u2019s syndrome: d- and l-amphetamine and haloperidol. J Am Acad Child Psychiatry 1984, 23:147\u2013152.","journal-title":"J Am Acad Child Psychiatry"},{"key":"4_CR24","first-page":"1025","volume":"44","author":"M Feinberg","year":"1979","unstructured":"Feinberg M, Carroll BJ: Effects of dopamine agonists and antagonists in Tourette\u2019s disease. Arch Gen Psychiatry 1979, 44:1025\u20131026.","journal-title":"Arch Gen Psychiatry"},{"key":"4_CR25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF00414035","volume":"29","author":"JL Meyeroff","year":"1973","unstructured":"Meyeroff JL, Snyder SH: Gilles de la Tourette\u2019s disease and minimal brain dysfunction: amphetamine isomers reveal catecholamine correlates in an affected patient. Psychopharmacologia 1973, 29:211\u2013220.","journal-title":"Psychopharmacologia"},{"key":"4_CR26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ana.410210313","volume":"21","author":"CG Goetz","year":"1987","unstructured":"Goetz CG, Tanner CM, Wilson RS, et al.: Clonidine and Gilles de la Tourette\u2019s syndrome: double-blind study using objective rating methods. Ann Neurol 1987, 21:307\u2013310.","journal-title":"Ann Neurol"},{"key":"4_CR27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1542\/peds.95.1.74","volume":"95","author":"HS Singer","year":"1995","unstructured":"Singer HS, Brown J, Quaskey S, et al.: The treatment of attention-deficit hyperactivity disorder in Tourette syndrome: a double-blind placebo-controlled study with clonidine and desipramine. Pediatrics 1995, 95:74\u201381.","journal-title":"Pediatrics"},{"key":"4_CR28","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/archpsyc.1991.01810280040006","volume":"48","author":"JF Leckman","year":"1991","unstructured":"Leckman JF, Hardin MT, Riddle MA, et al.: Clonidine treatment of Gilles de la Tourette syndrome. Arch Gen Psychiatry 1991, 48:324\u2013328.","journal-title":"Arch Gen Psychiatry"},{"key":"4_CR29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/cap.1995.5.155","volume":"5","author":"RR Fenichel","year":"1995","unstructured":"Fenichel RR: Post-marketing surveillance identifies three cases of sudden death in children during treatment with clonidine and methylphenidate. J Child Adolesc Psychopharmacol 1995, 5:155\u2013156.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"4_CR30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/cap.1995.5.157","volume":"5","author":"CW Popper","year":"1995","unstructured":"Popper CW: Combining methylphenidate and clonidine: news reports about sudden death. J Child Adolesc Psychopharmacol 1995, 5:157\u2013166.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"4_CR31","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1001\/archpsyc.1995.03950180030005","volume":"52","author":"KD Gadow","year":"1995","unstructured":"Gadow KD, Sverd J, Sprafkin J, et al.: Efficacy of methylphenidate for ADHD in children with tic disorder. Arch Gen Psychiatry 1995, 52:444\u2013455.","journal-title":"Arch Gen Psychiatry"},{"key":"4_CR32","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archpsyc.56.4.330","volume":"56","author":"KD Gadow","year":"1999","unstructured":"Gadow KD, Sverd J, Sprafkin J, et al.: Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder. Arch Gen Psychiatry 1999, 56:330\u2013336.","journal-title":"Arch Gen Psychiatry"},{"key":"4_CR33","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00004583-199705000-00008","volume":"36","author":"FX Castellanos","year":"1997","unstructured":"Castellanos FX, Giedd JN, Elia J, et al.: Controlled stimulant treatment of ADHD and comorbid Tourette\u2019s syndrome: effects of stimulant and dose. J Am Acad Child Adolesc Psychiatry 1997, 36:589\u2013596.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"4_CR34","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1212\/WNL.58.4.527","volume":"58","author":"The Tourette\u2019s Syndrome Study Group","year":"2002","unstructured":"The Tourette\u2019s Syndrome Study Group: Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 2002, 58:527\u2013536.This double-blind, placebo-controlled study involving 136 children with attention deficit hyperactivity disorder (ADHD) and tics found that tics lessened during treatment with methylphenidate (MPH) or clonidine, both drugs were effective for ADHD, and that the most effective treatment was combined use of MPH and clonidine.","journal-title":"Neurology"},{"key":"4_CR35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/mds.10094","volume":"17","author":"R Kurlan","year":"2001","unstructured":"Kurlan R: Methylphenidate to treat ADHD is not contraindicated in children with tics. Mov Disord 2001, 17:5\u20136.","journal-title":"Mov Disord"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-003-0004-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-003-0004-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-003-0004-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T18:31:20Z","timestamp":1707935480000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-003-0004-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["4"],"URL":"https:\/\/doi.org\/10.1007\/s11910-003-0004-2","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7]]}}}